Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones

Fabry_CEP is a user-friendly web-application designed to help clinicians Choose Eligible Patients for the therapy with pharmacological chaperones. It provides a database and a predictive tool to evaluate the responsiveness of lysosomal alpha-galactosidase mutants to a small molecule drug, namely 1-D...

Full description

Bibliographic Details
Main Authors: Cammisa, Marco, Correra, Antonella, Andreotti, Giuseppina, Cubellis, Maria Vittoria
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729670/
id pubmed-3729670
recordtype oai_dc
spelling pubmed-37296702013-08-01 Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones Cammisa, Marco Correra, Antonella Andreotti, Giuseppina Cubellis, Maria Vittoria Letter to the Editor Fabry_CEP is a user-friendly web-application designed to help clinicians Choose Eligible Patients for the therapy with pharmacological chaperones. It provides a database and a predictive tool to evaluate the responsiveness of lysosomal alpha-galactosidase mutants to a small molecule drug, namely 1-Deoxy-galactonojirimycin. The user can introduce any missense/nonsense mutation in the coding sequence, learn whether it is has been tested and gain access to appropriate reference literature. In the absence of experimental data structural, functional and evolutionary analysis provides a prediction and the probability that a given mutation is responsive to the drug. BioMed Central 2013-07-24 /pmc/articles/PMC3729670/ /pubmed/23883437 http://dx.doi.org/10.1186/1750-1172-8-111 Text en Copyright © 2013 Cammisa et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Cammisa, Marco
Correra, Antonella
Andreotti, Giuseppina
Cubellis, Maria Vittoria
spellingShingle Cammisa, Marco
Correra, Antonella
Andreotti, Giuseppina
Cubellis, Maria Vittoria
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
author_facet Cammisa, Marco
Correra, Antonella
Andreotti, Giuseppina
Cubellis, Maria Vittoria
author_sort Cammisa, Marco
title Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
title_short Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
title_full Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
title_fullStr Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
title_full_unstemmed Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
title_sort fabry_cep: a tool to identify fabry mutations responsive to pharmacological chaperones
description Fabry_CEP is a user-friendly web-application designed to help clinicians Choose Eligible Patients for the therapy with pharmacological chaperones. It provides a database and a predictive tool to evaluate the responsiveness of lysosomal alpha-galactosidase mutants to a small molecule drug, namely 1-Deoxy-galactonojirimycin. The user can introduce any missense/nonsense mutation in the coding sequence, learn whether it is has been tested and gain access to appropriate reference literature. In the absence of experimental data structural, functional and evolutionary analysis provides a prediction and the probability that a given mutation is responsive to the drug.
publisher BioMed Central
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729670/
_version_ 1611999598315831296